RVPH – reviva pharmaceuticals holdings, inc. (US:NASDAQ)
Stock Stats
News
Reviva Pharmaceuticals Holdings (RVPH) Records 37% in 2026 So far [Yahoo! Finance]
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia
Reviva Pharmaceuticals (NASDAQ:RVPH) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $2.00 price target on the stock.
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum [Yahoo! Finance]
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
Form SCHEDULE 13G/A REVIVA PHARMACEUTICALS Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Form 8-K REVIVA PHARMACEUTICALS For: Dec 18
Form SCHEDULE 13D/A REVIVA PHARMACEUTICALS Filed by: SAXENA PARAG
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Funtleyder Leslie D.
Form 4 REVIVA PHARMACEUTICALS For: Dec 18 Filed by: Patel Purav
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.